Anti-Melanoma Differentiation-Associated Gene 5 Is Associated with Rapidly Progressive Lung Disease and Poor Survival in US Patients with Amyopathic and Myopathic Dermatomyositis

Arthritis Care and Research

Volumn 68, Issue 5, 2016, Pages 689-694

  Moghadam Kia, Siamak ^a   Oddis, Chester V ^a   Sato, Shinji ^b   Kuwana, Masataka ^c   Aggarwal, Rohit ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b TOKAI UNIVERSITY   (Japan)

^c NIPPON MEDICAL SCHOOL GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; MELANOMA DIFFERENTIATION ASSOCIATED GENE 5 ANTIBODY; UNCLASSIFIED DRUG; INTERFERON INDUCED HELICASE C DOMAIN CONTAINING PROTEIN 1;

ADULT; ARTICLE; CLINICALLY AMYOPATHIC DERMATOMYOSITIS; COHORT ANALYSIS; CONTROLLED STUDY; DERMATOMYOSITIS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MYOPATHIC DERMATOMYOSITIS; PROGNOSIS; RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE; RISK ASSESSMENT; RISK FACTOR; SURVIVAL; UNITED STATES; BLOOD; CASE CONTROL STUDY; COMPLICATION; DISEASE COURSE; IMMUNOLOGY; MIDDLE AGED; SURVIVAL ANALYSIS;

ADULT; AUTOANTIBODIES; CASE-CONTROL STUDIES; DERMATOMYOSITIS; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERFERON-INDUCED HELICASE, IFIH1; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; UNITED STATES;

EID: 84964528178     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22728     Document Type: Article

References (16)

1. Bohan A, Peter JB., Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975; 292: 344-7.
2. Bohan A, Peter JB., Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975; 292: 403-7.
3. Euwer RL, Sontheimer RD., Amyopathic dermatomyositis (dermatomyositis sine myositis). Presentation of six new cases and review of the literature. J Am Acad Dermatol 1991; 24: 959-66.
4. Pearson, C., Arthritis and allied conditions: a textbook of rheumatology. 9th ed. Philadelphia (PA): Lea & Febiger; 1979.
5. Sontheimer RD., Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol 2002; 46: 626-36.
6. Gerami P, Schope JM, McDonald L, Walling HW, Sontheimer RD., A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis sine myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies. J Am Acad Dermatol 2006; 54: 597-613.
7. Sato S, Hirakata M, Kuwana M, Suwa A, Inada S, Mimori T, et al., Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum 2005; 52: 1571-6.
8. Gono T, Kawaguchi Y, Satoh T, Kuwana M, Katsumata Y, Takagi K, et al., Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis. Rheumatology (Oxford) 2010; 49: 1713-9.
9. Hamaguchi Y, Kuwana M, Hoshino K, Hasegawa M, Kaji K, Matsushita T, et al., Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study. Arch Dermatol 2011; 147: 391-8.
10. Nagata K, Tomii K, Nanjo S, Kubota M, Tachikawa R, Nishio M., Four cases of interstitial pneumonia associated with amyopathic dermatomyositis characterized by the anti-CADM-140 antibody. Nihon Kokyuki Gakkai Zasshi 2011; 49: 30-6. In Japanese.
11. Chen Z, Cao M, Plana MN, Liang J, Cai H, Kuwana M, et al., Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: a review of the literature and a meta-analysis. Arthritis Care Res (Hoboken) 2013; 65: 1316-24.
12. Hall JC, Casciola-Rosen L, Samedy LA, Werner J, Owoyemi K, Danoff SK, et al., Anti-melanoma differentiation-associated protein 5-associated dermatomyositis: expanding the clinical spectrum. Arthritis Care Res (Hoboken) 2013; 65: 1307-15.
13. Sato S, Hoshino K, Satoh T, Fujita T, Kawakami Y, Fujita T, et al., RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease. Arthritis Rheum 2009; 60: 2193-200.
14. Morganroth PA, Kreider ME, Okawa J, Taylor L, Werth VP., Interstitial lung disease in classic and skin-predominant dermatomyositis: a retrospective study with screening recommendations. Arch Dermatol 2010; 146: 729-38.
15. Fiorentino D, Chung L, Zwerner J, Rosen A, Casciola-Rosen L., The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study. J Am Acad Dermatol 2011; 65: 25-34.
16. Fujisawa T, Hozumi H, Kono M, Enomoto N, Hashimoto D, Nakamura Y, et al., Prognostic factors for myositis-associated interstitial lung disease. PLoS One 2014; 9: e98824.